Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -3.64 is 100% above its 5-year average of -5629.67, near the high end of its 5-year range (-12306.00–-3.64).
98.57% above its 12-month average of -254.03.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.08.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
EARNINGS PER SHARE (EPS)
-3.64
EARNINGS PER SHARE (EPS) AVG TTM
-254.03
EARNINGS PER SHARE (EPS) AVG 3Y
-3442.01
EARNINGS PER SHARE (EPS) AVG 5Y
-5629.67
EARNINGS PER SHARE (EPS) AVG 10Y
-81362.55
EARNINGS PER SHARE (EPS) AVG 15Y
-410449.87
EARNINGS PER SHARE (EPS) AVG 20Y
-1219001.56
CURRENT VS TTM AVG
+98.57%
CURRENT VS 3Y AVG
+99.89%
CURRENT VS 5Y AVG
+99.94%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
Bio Green Med Solution, Inc.
Market Cap
$4.64M
Earnings Per Share (EPS)
-3.64
TTM Avg
-254.03
3Y Avg
-3442.01
5Y Avg
-5629.67
Market Cap
$4.75M
Earnings Per Share (EPS)
-6.95
TTM Avg
-22.18
3Y Avg
-69.66
5Y Avg
-91.58
Market Cap
$4.77M
Earnings Per Share (EPS)
-5.32
TTM Avg
-8.47
3Y Avg
-12.67
5Y Avg
-14.30
Market Cap
$4.50M
Earnings Per Share (EPS)
-4.39
TTM Avg
-44.24
3Y Avg
-644.57
5Y Avg
-610.60
Market Cap
$4.45M
Earnings Per Share (EPS)
-2.41
TTM Avg
0.21
3Y Avg
-0.40
5Y Avg
-0.72
Market Cap
$4.34M
Earnings Per Share (EPS)
-9.39
TTM Avg
-11.95
3Y Avg
-11.32
5Y Avg
-8.88
Market Cap
$4.26M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.88
3Y Avg
-0.66
5Y Avg
-0.44
Market Cap
$5.23M
Earnings Per Share (EPS)
N/A
TTM Avg
0.00
3Y Avg
-0.12
5Y Avg
-0.11
Market Cap
$5.06M
Earnings Per Share (EPS)
-4.53
TTM Avg
-13.96
3Y Avg
-30.40
5Y Avg
-166.98
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio Green Med Solution, Inc. (BGMS) | $4.64M | -3.64 | -254.03 | -3442.01 | -5629.67 |
| CalciMedica, Inc. (CALC)vs › | $4.75M | -6.95 | -22.18 | -69.66 | -91.58 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.77M | -5.32 | -8.47 | -12.67 | -14.30 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.50M | -4.39 | -44.24 | -644.57 | -610.60 |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.45M | -2.41 | 0.21 | -0.40 | -0.72 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | -9.39 | -11.95 | -11.32 | -8.88 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.26M | -0.76 | -0.88 | -0.66 | -0.44 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.23M | N/A | 0.00 | -0.12 | -0.11 |
| Imunon, Inc. (IMNN)vs › | $5.06M | -4.53 | -13.96 | -30.40 | -166.98 |
| GRI Bio, Inc. (GRI)vs › | $4.09M | N/A | -60.73 | -46926.80 | -32538.00 |
Trailing EPS (TTM)
$-3.64
Forward EPS (Est.)
$-268.80
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -6.45 |
| 2024-12-31 | -501.60 |
| 2023-12-31 | -6420.00 |
| 2022-12-31 | -6840.00 |
| 2021-12-31 | -7704.00 |
| 2020-12-31 | -12306.00 |
| 2019-12-31 | -35426.00 |
| 2018-12-31 | -44584.00 |
| 2017-12-31 | -140400.00 |
| 2016-12-31 | -252000.00 |
| 2015-12-31 | -388800.00 |
| 2014-12-31 | -768960.00 |
| 2013-12-31 | -1105920.00 |
| 2012-12-31 | -1451520.00 |
| 2011-12-31 | -1935360.00 |
| 2010-12-31 | -3144960.00 |
| 2009-12-31 | -5322240.00 |
| 2008-12-31 | -11975040.00 |
| 2007-12-31 | -7318080.00 |
| 2006-12-31 | -14515200.00 |
| 2005-12-31 | -91324800.00 |
